●  Founders

●  Scientific Advisory Board

●  Management

Constellation Pharmaceuticals’ Scientific Advisory Board: A powerful set of industry leaders who have the critical insights across all facets of biomedical and oncology and expertise in basic science, disease biology, chemistry, development and medicine.


Julian Adams, Ph.D.
Chief Scientific Officer, Infinity Pharmaceuticals

Xiaodong Cheng, Ph.D.
Professor, Emory University

Thomas Jenuwein, Ph.D.
Director, Max Planck Institute

Rick Klausner, M.D.
Managing Partner, The Column Group
and former Director of the National Cancer Institute

Arnold Levine, Ph.D.
Professor, Institute for Advanced Studies

David Livingston, M.D.
Deputy Director, Dana Farber Harvard Cancer Center

Scott Lowe, Ph.D.
Professor, Cold Spring Harbor Laboratory

Robert Tjian, Ph.D.
Professor, University of California, Berkeley